US Stock MarketDetailed Quotes

SER Serina Therapeutics

Watchlist
  • 4.750
  • -0.100-2.06%
Close Mar 27 16:00 ET
47.18MMarket Cap-4.02P/E (TTM)

Serina Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
500.00%3M
3M
0
0
0
Operating revenue
--0
--0
--0
--0
--0
500.00%3M
--3M
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
178.15%17.05M
101.12%5.55M
263.09%5.31M
309.10%3.87M
141.27%2.32M
121.23%6.13M
2.76M
1.46M
945K
962K
Selling and administrative expenses
147.15%9.62M
63.49%3.17M
227.45%2.91M
391.12%2.32M
105.73%1.22M
202.15%3.89M
--1.94M
--889K
--473K
--593K
-General and administrative expense
147.15%9.62M
63.49%3.17M
227.45%2.91M
391.12%2.32M
105.73%1.22M
202.15%3.89M
--1.94M
--889K
--473K
--593K
Research and development costs
213.23%7.48M
160.75%2.37M
300.50%2.42M
232.78%1.59M
177.19%1.11M
51.80%2.39M
--907K
--603K
--479K
--399K
Other operating expenses
63.40%-56K
116.09%14K
51.72%-14K
-628.57%-51K
83.33%-5K
-67.21%-153K
---87K
---29K
---7K
---30K
Operating profit
-444.84%-17.05M
-2,402.49%-5.55M
-263.09%-5.31M
-309.10%-3.87M
-141.27%-2.32M
-37.82%-3.13M
241K
-1.46M
-945K
-962K
Net non-operating interest income expense
5.73%-526K
90.34%-17K
84.00%-16K
-124.07%-242K
-15.12%-99K
-3,851.56%-558K
-176K
-100K
-108K
-86K
Non-operating interest expense
-5.73%526K
-90.34%17K
-84.00%16K
124.07%242K
15.12%99K
3,414.30%558K
--176K
--100K
--108K
--86K
Other net income (expense)
-28.91%6.37M
185.40%2.81M
102.44%6.71M
398.93%9.29M
-359.31%-7.02M
2,352.41%8.96M
986K
3.32M
1.86M
2.71M
Gain on sale of security
1,121.54%13.16M
15,294.44%2.77M
1,018.96%6.67M
3,093.81%9.29M
----
917.75%1.08M
--18K
--596K
--291K
--172K
Other non- operating income (expenses)
-186.17%-6.79M
-95.56%43K
-98.46%42K
-100.57%-9K
-376.91%-7.02M
3,062.97%7.88M
--968K
--2.72M
--1.57M
--2.53M
Income before tax
-312.70%-11.21M
-361.85%-2.75M
-21.06%1.38M
540.72%5.18M
-669.18%-9.44M
296.45%5.27M
1.05M
1.75M
808K
1.66M
Income tax
Net income
-312.70%-11.21M
-361.85%-2.75M
-21.06%1.38M
540.72%5.18M
-669.18%-9.44M
296.45%5.27M
1.05M
1.75M
808K
1.66M
Net income continuous Operations
-312.70%-11.21M
-361.85%-2.75M
-21.06%1.38M
540.72%5.18M
-669.18%-9.44M
296.45%5.27M
--1.05M
--1.75M
--808K
--1.66M
Minority interest income
-66K
-12K
-27K
-27K
0
0
0
0
Net income attributable to the parent company
-311.44%-11.14M
-360.70%-2.74M
-19.52%1.41M
544.06%5.2M
-669.18%-9.44M
296.45%5.27M
1.05M
1.75M
808K
1.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-311.44%-11.14M
-360.70%-2.74M
-19.52%1.41M
544.06%5.2M
-669.18%-9.44M
296.45%5.27M
1.05M
1.75M
808K
1.66M
Basic earnings per share
-341.13%-1.51
-316.15%-0.27
-80.00%0.16
65.33%0.61
-546.45%-3.38
150.81%0.6262
0.1249
0.8
0.369
0.7571
Diluted earnings per share
-341.13%-1.51
-316.15%-0.27
-43.48%0.13
366.00%0.51
-1,646.08%-3.38
150.81%0.6262
0.1249
0.23
0.1094
0.2186
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 00000500.00%3M3M000
Operating revenue --0--0--0--0--0500.00%3M--3M--0--0--0
Cost of revenue
Gross profit
Operating expense 178.15%17.05M101.12%5.55M263.09%5.31M309.10%3.87M141.27%2.32M121.23%6.13M2.76M1.46M945K962K
Selling and administrative expenses 147.15%9.62M63.49%3.17M227.45%2.91M391.12%2.32M105.73%1.22M202.15%3.89M--1.94M--889K--473K--593K
-General and administrative expense 147.15%9.62M63.49%3.17M227.45%2.91M391.12%2.32M105.73%1.22M202.15%3.89M--1.94M--889K--473K--593K
Research and development costs 213.23%7.48M160.75%2.37M300.50%2.42M232.78%1.59M177.19%1.11M51.80%2.39M--907K--603K--479K--399K
Other operating expenses 63.40%-56K116.09%14K51.72%-14K-628.57%-51K83.33%-5K-67.21%-153K---87K---29K---7K---30K
Operating profit -444.84%-17.05M-2,402.49%-5.55M-263.09%-5.31M-309.10%-3.87M-141.27%-2.32M-37.82%-3.13M241K-1.46M-945K-962K
Net non-operating interest income expense 5.73%-526K90.34%-17K84.00%-16K-124.07%-242K-15.12%-99K-3,851.56%-558K-176K-100K-108K-86K
Non-operating interest expense -5.73%526K-90.34%17K-84.00%16K124.07%242K15.12%99K3,414.30%558K--176K--100K--108K--86K
Other net income (expense) -28.91%6.37M185.40%2.81M102.44%6.71M398.93%9.29M-359.31%-7.02M2,352.41%8.96M986K3.32M1.86M2.71M
Gain on sale of security 1,121.54%13.16M15,294.44%2.77M1,018.96%6.67M3,093.81%9.29M----917.75%1.08M--18K--596K--291K--172K
Other non- operating income (expenses) -186.17%-6.79M-95.56%43K-98.46%42K-100.57%-9K-376.91%-7.02M3,062.97%7.88M--968K--2.72M--1.57M--2.53M
Income before tax -312.70%-11.21M-361.85%-2.75M-21.06%1.38M540.72%5.18M-669.18%-9.44M296.45%5.27M1.05M1.75M808K1.66M
Income tax
Net income -312.70%-11.21M-361.85%-2.75M-21.06%1.38M540.72%5.18M-669.18%-9.44M296.45%5.27M1.05M1.75M808K1.66M
Net income continuous Operations -312.70%-11.21M-361.85%-2.75M-21.06%1.38M540.72%5.18M-669.18%-9.44M296.45%5.27M--1.05M--1.75M--808K--1.66M
Minority interest income -66K-12K-27K-27K0000
Net income attributable to the parent company -311.44%-11.14M-360.70%-2.74M-19.52%1.41M544.06%5.2M-669.18%-9.44M296.45%5.27M1.05M1.75M808K1.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -311.44%-11.14M-360.70%-2.74M-19.52%1.41M544.06%5.2M-669.18%-9.44M296.45%5.27M1.05M1.75M808K1.66M
Basic earnings per share -341.13%-1.51-316.15%-0.27-80.00%0.1665.33%0.61-546.45%-3.38150.81%0.62620.12490.80.3690.7571
Diluted earnings per share -341.13%-1.51-316.15%-0.27-43.48%0.13366.00%0.51-1,646.08%-3.38150.81%0.62620.12490.230.10940.2186
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes------------------
Market Insights
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Alibaba
BABA
+2.56%
Apple
AAPL
+1.05%
Intel
INTC
+0.85%
Netflix
NFLX
+0.63%
Tesla
TSLA
+0.39%

Unlock the Full List